Healthcare stocks were higher late Monday afternoon, with the NYSE Healthcare Index rising 1% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 1.4%.
The iShares Biotechnology ETF (IBB) climbed 1%.
In corporate news, Silence Therapeutics (SLN) shares jumped 25% after it said Monday its phase 2 trial of divesiran to treat Polychthemia Vera, a form of blood cancer, met its primary endpoint.